By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Sangui Biotech International, Inc.

Sangui Biotech International, Inc. (SGBI)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 2 Jul 2025, 20:00
$41.98K
Market Cap
0.33
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

SGBI Stock Price Chart

Explore Sangui Biotech International, Inc. interactive price chart. Choose custom timeframes to analyze SGBI price movements and trends.

SGBI Company Profile

Discover essential business fundamentals and corporate details for Sangui Biotech International, Inc. (SGBI) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

27 Mar 1997

Employees

CEO

Thomas Striepe

Description

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

SGBI Financial Timeline

Browse a chronological timeline of Sangui Biotech International, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 31 Mar 2023

EPS came in at -$0.00 , while revenue for the quarter reached $18.70K .

Earnings released on 31 Dec 2022

EPS came in at -$0.00 , while revenue for the quarter reached $10.63K .

Earnings released on 30 Sept 2022

EPS came in at $0.00 , while revenue for the quarter reached $41.03K .

Earnings released on 30 Jun 2022

EPS came in at $0.00 , while revenue for the quarter reached $10.50K .

Earnings released on 31 Mar 2022

EPS came in at -$0.00 , while revenue for the quarter reached $17.95K .

Earnings released on 31 Dec 2021

EPS came in at -$0.00 , while revenue for the quarter reached $22.17K .

Earnings released on 30 Sept 2021

EPS came in at -$0.00 , while revenue for the quarter reached $18.56K .

Earnings released on 30 Jun 2021

EPS came in at -$0.00 , while revenue for the quarter reached $13.83K .

Earnings released on 10 May 2021

EPS came in at -$0.00 , while revenue for the quarter reached $65.59K .

Earnings released on 31 Dec 2020

EPS came in at -$0.00 , while revenue for the quarter reached $10.69K .

Earnings released on 30 Sept 2020

EPS came in at -$0.00 , while revenue for the quarter reached $19.88K .

SGBI Stock Performance

Access detailed SGBI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run